Loxo Oncology CS (LOXO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LOXO | CORT | STVN | ||
| Company | Loxo Oncology CS | Corcept Therapeutics | Stevanato Group S.P.A. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | ||
| Open | 234.80 | 90.30 | 18.60 | ||
| High | 234.80 | 90.30 | 19.02 | ||
| Low | 234.80 | 86.82 | 18.57 | ||
| Latest | 234.80 | 90.21 | 19.00 | ||
| Change | +0.14 | +1.73 | +0.66 | ||
| % Change | +0.06% | +1.96% | +3.60% | ||
| Volume | 800 | 772,000 | 337,500 | ||
| 20-Day Average Volume | 642,620 | 1,005,375 | 393,825 | ||
| Previous Close | 234.66 | 88.48 | 18.34 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 234.28 | 81.89 | 17.62 | ||
| 20-Day Raw Stochastic | 92.26% | 95.78% | 78.00% | ||
| 20-Day Relative Strength | 75.87 | 79.61 | 59.93 | ||
| Weighted Alpha | +47.60 | +152.93 | -17.35 | ||
| Today's Opinion | 100% Buy | 88% Buy | 24% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 24% Buy | ||
| Last Month's Opinion | 56% Buy | 40% Buy | 8% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.16% since 02/08/19 | +6.44% since 06/25/26 | +3.32% since 06/25/26 | ||
| Low | 234.43 on 02/11/19 | 82.31 on 06/26/26 | 17.23 on 06/29/26 | ||
| High | 234.93 on 02/13/19 | 91.00 on 07/01/26 | 19.02 on 07/02/26 | ||
| 1-Month | |||||
| %Chg | +0.48% since 01/15/19 | +26.70% since 06/02/26 | +1.12% since 06/02/26 | ||
| Low | 233.14 on 01/16/19 | 70.07 on 06/03/26 | 16.27 on 06/16/26 | ||
| High | 234.93 on 02/13/19 | 91.00 on 07/01/26 | 19.77 on 06/05/26 | ||
| 3-Month | |||||
| %Chg | +54.95% since 11/15/18 | +112.31% since 04/02/26 | +38.38% since 04/02/26 | ||
| Low | 125.00 on 12/24/18 | 40.36 on 04/07/26 | 13.39 on 04/10/26 | ||
| High | 234.93 on 02/13/19 | 91.00 on 07/01/26 | 19.77 on 06/05/26 | ||
| 6-Month | |||||
| %Chg | +49.33% since 08/15/18 | +136.15% since 01/02/26 | -7.68% since 01/02/26 | ||
| Low | 125.00 on 12/24/18 | 28.66 on 02/19/26 | 12.89 on 03/27/26 | ||
| High | 234.93 on 02/13/19 | 91.00 on 07/01/26 | 22.00 on 01/08/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 7,182,943 | 9,684,223 | 5,754,017 | ||
| Shares Outstanding, K | 30,615 | 107,352 | 302,843 | ||
| Annual Sales | 21,300,000 | 761,410,000 | 1,342,160,000 | ||
| Annual Net Income | -148,880,000 | 99,650,000 | 158,210,000 | ||
| Last Quarter Sales | 42,470,000 | 164,900,000 | 320,190,000 | ||
| Last Quarter Net Income | -27,060,000 | -31,760,000 | 32,810,000 | ||
| 60-Month Beta | 2.51 | 0.47 | 0.78 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.89 on 11/08/18 | -0.30 on 04/30/26 | 0.13 on 05/07/26 | ||
| Earnings Date | 03/07/19 | 07/30/26 | 08/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 252.80 | 29.58 | ||